Kana Lessig Stemsoft Software ⭐

all of their CAR-T, IEC, and research work. Ensure compliance with 21 CFR Part 11, HIPAA, and GDPR.

At STEMSOFT, we believe in "Scientists Helping Scientists." With nearly three decades of experience, we provide in-house expertise and a dedicated support team to ensure your informatics solutions evolve alongside your science.

However, STEMSOFT is a leader in cell therapy informatics. Here is a blog post tailored to their specialized work. Kana Lessig Stemsoft Software

(e.g., a case study or press release).

STEMSOFT provides the industry's leading cellular therapy software solutions, designed specifically to manage this complexity. By offering comprehensive informatics solutions that focus on end-to-end information management, we empower providers to: all of their CAR-T, IEC, and research work

The field of cellular therapy is moving at breakneck speed. CAR-T, IEC, and other advanced therapy medicinal products (ATMPs) are revolutionizing patient care, transforming how we treat cancer and other diseases. Yet, with this incredible innovation comes a complex reality: managing the data of human cells as a raw material requires unprecedented precision.

STEMSOFT is a well-established division of , led by President and CEO Rob Fuller , and was founded in 1993 by Dr. Allen Eaves . However, STEMSOFT is a leader in cell therapy informatics

Manufacturing and administering advanced therapies requires complete, accurate, and detailed records. Whether you are a cord blood bank, a public marrow transplant center, or a commercial cell therapy manufacturer, the regulatory landscape is constantly evolving, requiring strict adherence to FACT/JACIE, AABB, cGMP, and cGTP standards.